Personal information

Activities

Funding (12)

Impact of Storage and Delivery Devices on Adenoviral Vectors

2021-01 to 2022-03 | Grant
West Pharmaceutical Services, Inc (Exton, US)
Source: Self-asserted source
Adam E. Snook

Clinical Translation of GUCY2C CAR-T-Cell Therapy

2017-10-01 to 2018-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
GRANT_NUMBER:

W81XWH-19-1-0263

Source: Self-asserted source
Adam E. Snook via DimensionsWizard

Decoy Ligand-Type CAR-T Cells for the Induction of Immune Tolerance

2017-10-01 to 2018-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
GRANT_NUMBER:

W81XWH-19-1-0067

Source: Self-asserted source
Adam E. Snook via DimensionsWizard

Metastatic Colorectal Cancer Immunotherapy with GUCY2C-Expressing Listeria monocytogenes

2017-09-01 to 2019-08-31 | Grant
United States Army (Washington, US)
GRANT_NUMBER:

grant.W81XWH1710299

Source: Self-asserted source
Adam E. Snook via DimensionsWizard

(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation

Source: Self-asserted source
Adam E. Snook via DimensionsWizard

Elimination of Adoptive Cell Therapy (ACT) Toxicity by Hypoxic Regulation of Antigen Receptors

2016-01 to 2016-12 | Grant
W. W. Smith Charitable Trust (PA, PA, US)
Source: Self-asserted source
Adam E. Snook

Combination Immunoradiotherapy Preclinical Evaluation of Efficacy, Sequencing and Biomarkers in Prostate Cancer

2015-11 to 2019-11 | Grant
Advaxis (Princeton, NJ, US)
Source: Self-asserted source
Adam E. Snook

GUCY2C-specific CD4+ T cell tolerance mechanisms and outcomes in tumor immunity

2014-07 to 2016-12 | Grant
Margaret Q. Landenberger Research Foundation (New York, US)
Source: Self-asserted source
Adam E. Snook

GUCY2C-specific tolerance in colon cancer patients

2014-07 to 2015-09 | Grant
Pharmaceutical Research and Manufacturers of America Foundation (DC, DC, US)
GRANT_NUMBER:

Research Starter Grant in Translational Medicine and Therapeutics.

Source: Self-asserted source
Adam E. Snook

GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1

Source: Self-asserted source
Adam E. Snook via DimensionsWizard

Occult tumor burden as a marker stratifying therapy to eliminate racial disparities in colon cancer

2010-06 to 2014-08 | Grant
Commonwealth Universal Research Enhancement (CURE) (Harrisburg, PA, US)
GRANT_NUMBER:

SAP #4100059197

Source: Self-asserted source
Adam E. Snook

Therapeutic vaccine bridging the gap in racial disparities in colorectal cancer

2010-06 to 2014-05 | Grant
Commonwealth Universal Research Enhancement (CURE) (Harrisburg, PA, US)
GRANT_NUMBER:

SAP #4100051723

Source: Self-asserted source
Adam E. Snook